In vitro assays showed that Linarin dose-dependently (0-200 μM) inhibited NSCLC cell proliferation, induced G0/G1 phase arrest, and promoted cellular senescence and apoptosis in both cell lines, irrespective of p53 status. Here, TP53 is linked to non-small cell lung carcinoma.